Epigenetics - A helpful tool to better understand processes in clinical nephrology?

Nephrology Dialysis Transplantation

Volumn 23, Issue 5, 2008, Pages 1493-1496

  Stenvinkel, Peter ^a,b   Ekström, Tomas J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic kidney disease; Epigenetics; Genetics; Homocysteine; Inflammation

Indexed keywords

DNA; HISTONE; INTERLEUKIN 6;

AGING; AUTOIMMUNE DISEASE; CHROMATIN; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; DYSLIPIDEMIA; EDITORIAL; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; HUMAN; HUMAN GENOME; HYPERHOMOCYSTEINEMIA; INFLAMMATION; KIDNEY FUNCTION; NEPHROLOGY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; UREMIA; VASCULAR DISEASE;

DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; PHENOTYPE; TELOMERE; UREMIA;

EID: 43849095576     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn056     Document Type: Editorial

References (46)

1. Nordfors L, Lindholm B, Stenvinkel P. End-stage renal disease - not an equal opportunity disease: the role of genetic polymorphisms. J Int Med 2005; 258: 1-12
2. Richards EJ. Inherited epigenetic variation - revisiting soft inheritance. Nat Rev 2006; 7: 395-400
3. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-692
4. Fraga MF, Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet 2007; 23: 413-418
5. Gray S, De Meyts P. Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab Res Rev 2005; 21: 416-433
6. Richardsson B, Scheinbart L, Strahler J et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990; 33: 1665-1673
7. Dong C, Yoon W, Goldsmith-Clermont PJ. DNA methylation and atherosclerosis. J Nutr 2002; 132: 2406S-2409S
8. Bogdarina I, Welham S, King PJ et al. Epigenetic modifications of the renin-angiotensin system in the fetal programming of hypertension. Circ Res 2007; 100: 520-526
9. Sinclair KD, Allegrucci C, Singh R et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconcenptional B vitamin and methionine status. Proc Natl Acad Sci USA 2007; 104: 19351-19356
10. Pembrey ME, Bygren LO, Kaati G et al. Sex-specific, male-line transgenerational responses in humans. Eur J Hum Genet 2006; 14: 159-166
11. Kaati G, Bygren LO, Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet 2002; 10: 682-688
12. Falque V, Casanova P, Barnay C et al. Discordant evolution in monozygotic twins with familial nephropathy. Pediatrie 1989; 44: 375-377
13. Fraga MF, Ballestar E, Paz MF et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci 2005; 102: 10604-10609
14. Shen L, Waterland RA. Methods of DNA methylation analysis. Curr Opin Clin Nutr Metab Care 2007; 10: 576-581
15. Andersen CL, Koch J, Kjeldsen E. CpG islands detected by self-primed in situ labeling (SPRINS). Chromosoma 1998; 107: 260-266
16. Liang G, Gonzalgo ML, Salem C et al. Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction. Methods 2002; 27: 150-155
17. Azhikina T, Gainetdinov I, Skvortsova Y et al. Non-methylated Genomic Sites Coincidence Cloning (NGSCC): an approach to large scale analysis of hypomethylated CpG patterns at predetermined genomic loci. Mol Genet Genomics 2004; 271: 22-32
18. Yan PS, Chen CM, Shi H et al. Applications of CpG island microarrays for high-throughput analysis of DNA methylation. J Nutr 2002; 132(8 Suppl): 2430S-2434S
19. Chen CM, Chen HL, Hsiau TH et al. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes. Am J Pathol 2003; 163: 37-45
20. Karimi M, Johansson S, Stach D et al. LUMA (Luminometric Methylation Assay) -a high throughput method to the analysis of genomic DNA methylation. Exp Cell Res. 2006; 312: 1989-1995
21. Rush LJ, Plass C. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Anal Biochem 2002; 307: 191-201
22. Stach D, Schmitz O, Stilgenbauer S et al. Capillary electrophoretic analysis of genomic DNAmethylation levels. Nucleic Acids Res 2003; 31: E2
23. Herman JG, Graff JR, Myöhänen S et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826
24. Colella S, Shen L, Baggerly KA et al. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 2003; 35: 146-150
25. Taylor KH, Kramer RS, Davis JW et al. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 2007; 67: 8511-8518
26. Ingrosso D, Cimmino A, Perna AF et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinemia in patients with uremia. Lancet 2003; 361: 1693-1699
27. Zaina S, Wickström Lindholm M, Lund G. Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia. J Nutr 2005; 135: 5-8
28. Stenvinkel P, Karimi M, Johansson S et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Int Med 2007; 261: 488-499
29. Stam F, van Guldener C, ter Wee PM et al. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine. Am J Physiol Renal Physiol 2004; 287: F215-F223
30. Castro R, Rivera I, Struys EA et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003; 49: 1292-1296
31. Yi P, Melnyk S, Pogribna M et al. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275: 29318-29323
32. Suliman ME, Barany P, Kalantar-Zadeh K et al. Homocysteine in uraemia - a puzzling and conflicting story. Nephrol Dial Transplant 2005; 20: 16-21
33. Teitell M, Richardson B. DNA methylation in the immune system. Clin Immunol 2003; 109: 2-5
34. Hodge DR, Xiao W, Clausen PA et al. Interleukin-6 regulation of the human DNA metyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 2001; 276: 39508-39511
35. Hodge DR, Peng B, Cherry JC et al. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promotor methylation. Cancer Res 2005; 65: 4673-4682
36. Hori Y, Oda Y, Kiyoshima K et al. Oxidative stress and DNA hypermetylation status in renal cell carcinoma arising in patients on dialysis. J Pathol 2007; 212: 218-226
37. Meehan R, Lewis J, Cross S et al. Transcriptional regression by methylation of CpG. J Cell Sci 1992; 16(Suppl): 9-14
38. Yin H, Blanchard KL. DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms. Blood 2000; 95: 111-119
39. Lund G, Andersson L, Lauria M et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004; 279: 29147-29154
40. Post WS, Goldschmidt-Clermont PJ, Wilhide CC et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999; 43: 985-991
41. Fitzpatrick AL, Kronmal RA, Gardner JP et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 2007; 165: 14-21
42. Carrero JJ, Stenvinkel P, Fellström B et al. Telomere attrition is associated to inflammation, low fetuin-A levels and high mortality in prevalent hemodialysis patients. J Int Med 2007, 3: 302-312
43. Benetti R, Garcia-Caoi M, Blasco MA. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genetic 2007; 39: 243-250
44. Blasco MA. The epigenetic regulation of mammalian telomeres. Nat Rev 2007; 8: 299-309
45. Ptak C, Petronis A. Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharamacol Toxicol 2008; 48: 257-276
46. Day JK, Bauer AM, desBordes C et al. Genistein alters methylation patterns in mice. J Nutr 2002; 132: 2419S-2423S